As of April 16, 2025, Adaptive Biotechnologies (ADPT) has a market cap of $1.15 billion USD. According to our data, Adaptive Biotechnologies is ranked No.4803 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $1.15 B |
29.99%
|
Dec 31, 2024 | $0.88 B |
22.35%
|
Dec 29, 2023 | $0.72 B |
-35.86%
|
Dec 30, 2022 | $1.13 B |
-72.77%
|
Dec 31, 2021 | $4.14 B |
-52.55%
|
Dec 31, 2020 | $8.73 B |
97.63%
|
Dec 31, 2019 | $4.42 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Illumina
ILMN
|
$11.80 B |
-0.000 M
|
![]() USA
|
![]() Thermo Fisher Scientific
TMO
|
$166.47 B |
0.002 M
|
![]() USA
|
![]() Bio-Rad Laboratories
BIO
|
$6.82 B |
1.204 B
|
![]() USA
|
![]() Guardant Health
GH
|
$5.54 B |
0.000 M
|
![]() USA
|
![]() Natera
NTRA
|
$20.51 B |
-0.000 M
|
![]() USA
|
![]() 10x Genomics
TXG
|
$1.00 B |
0.115 B
|
![]() USA
|
![]() Pacific Biosciences
PACB
|
$0.38 B |
-0.000 M
|
![]() USA
|
![]() NeoGenomics
NEO
|
$1.22 B |
0.000 M
|
![]() USA
|
![]() Personalis
PSNL
|
$0.29 B |
0.000 M
|
![]() USA
|
![]() Twist Bioscience
TWST
|
$2.36 B |
-0.000 M
|
![]() USA
|
![]() Adaptive Biotechnologies
ADPT
|
$1.15 B |
0.000 M
|
![]() USA
|
![]() Fulgent Genetics
FLGT
|
$0.59 B |
0.000 M
|
![]() USA
|
![]() Veracyte
VCYT
|
$2.48 B |
0.000 M
|
![]() USA
|
Market Cap | = | ADPT Stock Price | * | ADPT Shares Outstanding |
= | $7.74 | * | 0.15 B | |
= | $1.15 B |